These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Immunological evaluation of an alginate-based conjugate as a vaccine candidate against Pseudomonas aeruginosa. Farjah A; Owlia P; Siadat SD; Mousavi SF; Ardestani MS; Mohammadpour HK APMIS; 2015 Feb; 123(2):175-83. PubMed ID: 25470757 [TBL] [Abstract][Full Text] [Related]
3. Efficacy of a conjugate vaccine containing polymannuronic acid and flagellin against experimental Pseudomonas aeruginosa lung infection in mice. Campodónico VL; Llosa NJ; Bentancor LV; Maira-Litran T; Pier GB Infect Immun; 2011 Aug; 79(8):3455-64. PubMed ID: 21628521 [TBL] [Abstract][Full Text] [Related]
4. Immunization with outer membrane proteins (OprF and OprI) and flagellin B protects mice from pulmonary infection with mucoid and nonmucoid Pseudomonas aeruginosa. Hassan R; El-Naggar W; Abd El-Aziz AM; Shaaban M; Kenawy HI; Ali YM J Microbiol Immunol Infect; 2018 Jun; 51(3):312-320. PubMed ID: 28291719 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and characterization of Pseudomonas aeruginosa alginate-tetanus toxoid conjugate. Kashef N; Behzadian-Nejad Q; Najar-Peerayeh S; Mousavi-Hosseini K; Moazzeni M; Djavid GE J Med Microbiol; 2006 Oct; 55(Pt 10):1441-1446. PubMed ID: 17005795 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of the immune responses following co-administration of PilQ and type b-flagellin from Pseudomonas aeruginosa in the burn mouse model. Bakht Azad S; Nikokar I; Faezi S; Rasooly S; Mahdavi M Microb Pathog; 2018 Oct; 123():426-432. PubMed ID: 30075242 [TBL] [Abstract][Full Text] [Related]
7. Immunization with Bivalent Flagellin Protects Mice against Fatal Behrouz B; Hashemi FB; Fatemi MJ; Naghavi S; Irajian G; Halabian R; Imani Fooladi AA J Immunol Res; 2017; 2017():5689709. PubMed ID: 29201922 [No Abstract] [Full Text] [Related]
8. Conjugation of alginate to a synthetic peptide containing T- and B-cell epitopes as an induction for protective immunity against Pseudomonas aeruginosa. Farjaha A; Owlia P; Siadat SD; Mousavi SF; Shafieeardestani M J Biotechnol; 2014 Dec; 192 Pt A():240-7. PubMed ID: 25449544 [TBL] [Abstract][Full Text] [Related]
9. Immunization of young African green monkeys with OprF epitope 8-OprI-type A- and B-flagellin fusion proteins promotes the production of protective antibodies against nonmucoid Pseudomonas aeruginosa. Weimer ET; Ervin SE; Wozniak DJ; Mizel SB Vaccine; 2009 Nov; 27(48):6762-9. PubMed ID: 19744586 [TBL] [Abstract][Full Text] [Related]
10. Construction and characterization of a Pseudomonas aeruginosa mucoid exopolysaccharide-alginate conjugate vaccine. Theilacker C; Coleman FT; Mueschenborn S; Llosa N; Grout M; Pier GB Infect Immun; 2003 Jul; 71(7):3875-84. PubMed ID: 12819072 [TBL] [Abstract][Full Text] [Related]
11. Intranasal Peptide-Based FpvA-KLH Conjugate Vaccine Protects Mice From Sen-Kilic E; Blackwood CB; Boehm DT; Witt WT; Malkowski AC; Bevere JR; Wong TY; Hall JM; Bradford SD; Varney ME; Damron FH; Barbier M Front Immunol; 2019; 10():2497. PubMed ID: 31708925 [No Abstract] [Full Text] [Related]
12. New possibility for providing protection against urinary tract infection caused by Pseudomonas aeruginosa by non-adjuvanted flagellin 'b' induced immunity. Sabharwal N; Chhibber S; Harjai K Immunol Lett; 2014 Dec; 162(2 Pt B):229-38. PubMed ID: 25455605 [TBL] [Abstract][Full Text] [Related]
13. A fusion protein vaccine containing OprF epitope 8, OprI, and type A and B flagellins promotes enhanced clearance of nonmucoid Pseudomonas aeruginosa. Weimer ET; Lu H; Kock ND; Wozniak DJ; Mizel SB Infect Immun; 2009 Jun; 77(6):2356-66. PubMed ID: 19349426 [TBL] [Abstract][Full Text] [Related]
14. Protective efficacy of recombinant exotoxin A--flagellin fusion protein against Pseudomonas aeruginosa infection. Farajnia S; Peerayeh SN; Tanomand A; Majidi J; Goudarzi G; Naghili B; Rahbarnia L Can J Microbiol; 2015 Jan; 61(1):60-4. PubMed ID: 25496361 [TBL] [Abstract][Full Text] [Related]
15. Passive immunisation against Pseudomonas aeruginosa recombinant flagellin in an experimental model of burn wound sepsis. Faezi S; Sattari M; Mahdavi M; Roudkenar MH Burns; 2011 Aug; 37(5):865-72. PubMed ID: 21334822 [TBL] [Abstract][Full Text] [Related]
16. Protective efficacy of Pseudomonas aeruginosa type-A flagellin in the murine burn wound model of infection. Faezi S; Safarloo M; Amirmozafari N; Nikokar I; Siadat SD; Holder IA; Mahdavi M APMIS; 2014 Feb; 122(2):115-27. PubMed ID: 23758581 [TBL] [Abstract][Full Text] [Related]
17. Flagellin and pilin immunization against multi-drug resistant Pseudomonas aeruginosa protects mice in the burn wound sepsis model. Korpi F; Hashemi FB; Irajian G; Fatemi MJ; Laghaei P; Behrouz B Immunol Lett; 2016 Aug; 176():8-17. PubMed ID: 27210422 [TBL] [Abstract][Full Text] [Related]
18. Induction of humoral immune response against Pseudomonas aeruginosa flagellin(1-161) using gold nanoparticles as an adjuvant. Dakterzada F; Mohabati Mobarez A; Habibi Roudkenar M; Mohsenifar A Vaccine; 2016 Mar; 34(12):1472-9. PubMed ID: 26868080 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of flagella and flagellin of Pseudomonas aeruginosa as vaccines. Campodónico VL; Llosa NJ; Grout M; Döring G; Maira-Litrán T; Pier GB Infect Immun; 2010 Feb; 78(2):746-55. PubMed ID: 19995892 [TBL] [Abstract][Full Text] [Related]
20. Immunogenicity evaluating of the SLNs-alginate conjugate against Pseudomonas aeruginosa. Afshari H; Maleki M; Hakimian M; Tanha RA; Salouti M J Immunol Methods; 2021 Jan; 488():112938. PubMed ID: 33259781 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]